In April 2014, the Food and Drug Administration (FDA) reclassified the risks associated with use of the transvaginal mesh from “moderate” to “high” after more than 80,000 women filed claims against the manufacturer. In July 2011, the FDA reported that complications of transvaginal mesh use can be “life altering” – it was even revealed that pain symptoms could continue unabated long after the mesh was removed. A study published in the New England Journal of Medicine found that the transvaginal mesh was responsible for many serious side effects such as frequent pain, surgical complications and a risk of bladder perforation that was found to be seven times the norm.